GlassScriptPhysician profile
Abraham Adam
NPI 1154063519
$2,708.29
in general payments reported to CMS, 2019-2025
10 companies · $2,619 in 2025
The $2,619 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.11 · 2024: $67.24 · 2025: $2,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701 · Travel and Lodging: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.00 |
| Travel and Lodging | $1,007.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $967.56 | 2025 | |
| Treace Medical Concepts, INC. | $696.59 | 2025 | |
| Kerecis Limited | $370.32 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $177.77 | 2025 | Hoffmann, Augment Injectable |
| Linvatec Corporation | $135.98 | 2025 | Hercules Syndesmosis Implant System, Quantum, Neospan |
| Depuy Synthes Sales INC. | $134.21 | 2025 | Na |
| Zimmer Biomet Holdings, INC. | $92.34 | 2024-2025 | A.L.P.S., Stratum Foot Plating System |
| Fusion Orthopedics USA, LLC | $61.70 | 2025 | |
| Blue Surgical LLC | $49.71 | 2025 | |
| Smith+Nephew, INC. | $22.11 | 2023 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Adam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.